Farmaci e genoma - Università degli Studi di Verona
Farmaci e genoma - Università degli Studi di Verona
Farmaci e genoma - Università degli Studi di Verona
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
36<br />
in IRS-1 gene. Diabetologia 1996; 39: 600.<br />
◆ 9) Laakso M et al. Insulin receptor substrate-1<br />
variants in non-insulin-dependent <strong>di</strong>abetes. J Clin<br />
Invest 1994; 94: 1141.<br />
◆ 10) Grant PJ et al. Insulin receptor substrate-1 gene<br />
and car<strong>di</strong>ovascular risk factors in NIDDM. Lancet<br />
1995; 346: 841.<br />
◆ 11) Shimokawa K et al. Molecular scanning of the<br />
glycogen synthase and insulin receptor substrate-1 in<br />
Japanese subjects with non-insulin-dependent <strong>di</strong>abetes<br />
mellitus. Biochem Biophys Res Commun 1994;<br />
202: 463.<br />
◆ 12) Lee-Ming C et al. No association between the<br />
Gly972 Arg variant of the insulin receptor substrate-1<br />
gene and NIDDM in Taiwanese population. Diabetes<br />
Care 1996; 19: 446.<br />
◆ 13) ‘t Hart LM. et al. Prevalence of variants in can<strong>di</strong>date<br />
genes for type 2 <strong>di</strong>abetes mellitus in the<br />
Netherlands: the Rotterdam study and the Hoorn<br />
study. J. Clin. Endocrinol. Metab. 1999, 84: 1002.<br />
◆ 14) Lei HH et al. Variants of the insulin receptor substrate-1<br />
and fatty acid bin<strong>di</strong>ng protein 2 genes and<br />
the risk of type 2 <strong>di</strong>abetes, obesity, and hyperinsulinemia<br />
in African-Americans: the Atherosclerosis Risk<br />
in Communities Study. Diabetes 1999; 48: 1868.<br />
◆ 15) Celi F et al. Lack of IRS-1 codon 513 and 972<br />
polymorphism in Pima In<strong>di</strong>ans. J Clin Endocrinol<br />
Metab 1995; 80: 2827.<br />
◆ 16) Hribal ML et al. The Gly→Arg972 amino acid<br />
polymorphism in insulin receptor substrate-1 affects<br />
glucose metabolism in skeletal muscle cells. J Clin<br />
Endocrinol Metab 2000; 85: 2004.<br />
◆ 17) Porzio O et al. The Gly→Arg972 amino acid<br />
polymorphism in IRS-1 impairs insulin secretion in<br />
pancreatic beta cells. J Clin Invest 1999; 104: 357.<br />
◆ 18) Federici M et al. The common Gly→Arg972<br />
polymorphism in insulin receptor substrate-1 causes<br />
apoptosis of human pancreatic islets. FASEB J 2001;<br />
15: 22.<br />
◆ 19) Inoue H et al. Sequence variants in the sulfonylurea<br />
receptor (SUR) gene are associated with<br />
NIDDM in caucasians. Diabetes 1996; 45: 825.<br />
◆ 20) Hani EH et al. Genetic stu<strong>di</strong>es of the sulfonylurea<br />
receptor gene locus in NIDDM and in morbid obesity<br />
among French caucasians. Diabetes 1997, 46: 688.<br />
◆ 21) Hart LM et al. Variants in the sulphonylurea<br />
receptor gene: association of the exon 16-3T variant<br />
with Type II <strong>di</strong>abetes mellitus in dutch caucasians.<br />
Diabetologia 1999; 42: 617.<br />
◆ 22) Hart LM et al. Reduced second phase insulin<br />
secretion in carriers of a sulphonylurea receptor gene<br />
variant associating with Type II <strong>di</strong>abetes mellitus.<br />
Diabetologia. 2000; 43: 515.<br />
◆ 23) Hansen T et al. Decreased tolbutamide-stimulated<br />
insulin secretion in healthy subjects with sequence<br />
variants in the high-affinity sulfonylurea receptor<br />
gene. Diabetes 1998; 47: 598.